Developing an Oncology Workforce for the 21st Century - Renewal 01

 描述（由申请人提供）：芝加哥大学K12肿瘤学项目的总体目标是培养下一代高技能的学术肿瘤学家，他们能够设计和管理假设驱动的试点/I期，II期和III期癌症治疗试验和观察性研究。为了做到这一点，我们在学术严格的培训环境中创建了一个结构紧凑和指导的教育计划，为学术肿瘤学职业生涯准备了最引人注目的申请人。该计划是锚定在我们的综合癌症中心，并由Olufunmilayo Olopade，医学博士沿着与埃弗雷特沃克斯，医学博士与执行委员会以及内部和外部咨询委员会的大力支持。该保罗卡拉布雷西K12学者计划是我们的高度指导，教学课程密集型计划，和“动手”临床研究培训，导致在健康研究/临床调查科学硕士。利用整个大学的资源，我们已经创建了一套综合的跨学科课程，在转化科学，融合基因组学，社会科学，基于社区，临床和生物信息学，以及人口研究。在第一个资助周期，该计划已成功招募5名医学肿瘤学家，2名外科肿瘤学家和4名博士科学家，他们获得了广泛的研究培训和全面的经验，在团队研究环境中进行以患者为导向的癌症治疗研究，并将研究工作集中在以患者为导向的研究上。这个保罗·卡拉布雷西学者计划的一个明确目标，与我们机构的所有培训计划一样，是它的培训机会和好处将远远超出它将提供的相对较少的学者。该计划已经产生了变革性的全球影响，并正在进入芝加哥更大的“全球”肿瘤学实习生社区，以及来自其他国家的年轻肿瘤学家，他们作为全球健康学者来到我们的机构接受培训。因此，该方案的实施带来的好处是巨大的。

 DESCRIPTION (provided by applicant): The overall goal of the University of Chicago K12 program in Oncology is to produce the next generation of highly skilled academic Oncologists who are capable of designing and administering hypothesis-driven pilot/Phase I, Phase II and Phase III cancer therapeutic trials and observational studies. To do this, we have created a tightly structured and mentored education program within an academically rigorous training environment that prepares the most compelling applicants for careers in academic oncology. The program is anchored within our Comprehensive Cancer Center and led by Olufunmilayo Olopade, MD along with Everett Vokes, MD with strong support from an Executive Committee as well as Internal and External Advisory Committees. The Paul Calabresi K12 Scholars Program is our highly mentored, didactic coursework-intensive program, and "hands on" clinical research training which results in a Master of Science in Health Studies/Clinical Investigations. Leveraging resources across the University, we have created a set of integrated interdisciplinary courses in translational science that blends genomics, social sciences, community based, clinical- and bio-informatics, and population studies. In its 1st funding cycle, the program has been successful in recruiting 5 Medical Oncologists, 2 Surgical Oncologists and 4 PhD Scientists who obtain the broad research training and comprehensive experience necessary to conduct patient-oriented cancer therapeutic research in team research environments, and to focus their research endeavors on patient-oriented research. An explicit goal of this Paul Calabresi Scholars program, as with all training programs in our institution, is that its training opportunities and benefits will extend far beyond the relatively few scholars whose stipends it will provide. The program has had a transformative and global impact and is reaching into the larger "global" oncology trainee community in Chicago and to young oncologists from other countries who come to train at our Institution as Global Health Scholars. Thus, the benefit that accrues from the program's implementation is substantial.